Susan Rodriguez
About Susan Rodriguez
Susan Rodriguez is the Chief Commercial Officer with over 30 years of experience in the biopharmaceutical industry, having held significant leadership roles at Tolmar Pharmaceuticals and Abbott Laboratories.
Susan Rodriguez: Chief Commercial Officer
Susan Rodriguez currently serves as the Chief Commercial Officer. She brings over 30 years of experience in the biopharmaceutical industry to her role. Leveraging her extensive background, she contributes strategic commercial insights and leadership to the company.
Susan Rodriguez's Education and Expertise in Biopharmaceuticals
Susan Rodriguez holds both a Master of Science (M.S.) and a Bachelor of Science (B.S.) in Psychology from the University of Pennsylvania. This educational foundation in psychology has supported her career in the biopharmaceutical industry, where she has developed extensive expertise in commercial leadership, global marketing, and portfolio strategy.
Leadership Roles at Tolmar Pharmaceuticals
Susan Rodriguez served as the Chief Executive Officer of Tolmar Pharmaceuticals, Inc. from 2014 to 2019. Subsequently, she was named President of the branded division of Tolmar, Inc. in 2019. Her leadership at Tolmar included overseeing business operations and strategic growth initiatives in the biopharmaceutical sector.
Susan Rodriguez's Tenure at Abbott Laboratories
Susan Rodriguez held various leadership positions at Abbott Laboratories from 1990 to 2014. In her most recent role as Divisional Vice President of Global Marketing, she led the global marketing and portfolio strategy function. She also served as Vice President and General Manager of the Abbott Renal Franchise. She contributed to the launch of a next-generation therapy in the injectable vitamin D market and worked across multiple therapeutic areas, including neuroscience, cardiovascular, urology, gastroenterology, and anti-infective.
Susan Rodriguez's Role in Abbott-Takeda Joint Venture TAP
During her career at Abbott, Susan Rodriguez also worked at the Abbott-Takeda joint venture known as TAP. Her contributions at TAP involved various commercial leadership roles, further broadening her experience in the global pharmaceutical industry.